Seira Taniguchi, PhD, Ariko Yamamoto, PhD
Jpn J Compr Rehabil Sci 14: 16-25, 2023
Objective: To systematically review the evaluation of
clinimetric properties and feasibility of the "Modified
Parkinson Activity Scale (M-PAS)" and the "Lindop
Parkinson's Disease Mobility Assessment (LPA)," which
are Parkinson's Disease (PD)-specific measurement
instruments to assess basic functional mobility, and to
discuss their considerations for use in clinical practice.
Methods: A systematic review was conducted in
accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses guidelines. A
risk of bias assessment was also performed.
Results: Eleven studies were included: five studies
used M-PAS (45%), five studies used LPA (45%), and
one study used M-PAS and LPA (13%). The risk of
bias was low for all evaluated studies.
Conclusion: M-PAS and LPA showed adequate
reliability, validity, and responsiveness in detecting
intervention changes. M-PAS has more detailed
qualitative scoring options, a lack of ceiling effect, and
can be used by a non-expert in PD.
In contrast, the drawback of M-PAS is that it is timeconsuming
to apply in everyday clinical practice. On
the other hand, LPA with greater simplicity may lead
to lower burdens for both patients and raters in
situations with strict time limitations. Further research
is required to identify new resources.
Key words: literature review study, Parkinson's disease, basic functional mobility, measurement instruments, Modified Parkinson Activity Scale (M-PAS), Lindop Parkinson's Disease Mobility Assessment (LPA)